NCT04928508 2026-03-05
Okgyn1
University of Oklahoma
Phase 1 Recruiting
Clinical Trials
9 trialsNCT06265688 2026-02-20
First In Human Study of CX-2051 in Advanced Solid Tumors
CytomX Therapeutics
Phase 1 Recruiting
NCT03772561 2025-07-22
MEDIPAC
National University Hospital, Singapore
Phase 1 Recruiting
NCT06462794 2024-09-19
First In Human Study of CX-801 in Advanced Solid Tumors
CytomX Therapeutics
Phase 1 Recruiting
NCT06477614 2024-06-27
Anti-cancer DC Cell Vaccination to Treat Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
Phase 1 Recruiting
NCT06195293 2024-06-26
Anti-cancer Neoantigen Polypeptide Vaccine to Treat Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
Phase 1 Recruiting
NCT06433726 2024-05-30
A Phase l Study of By101921, an Oral PARP7 Inhibitor, in Patients With Advanced Solid Tumors
Chengdu Baiyu Pharmaceutical Co., Ltd.
Phase 1 Recruiting
NCT05868174 2024-05-01
Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 1 Recruiting
NCT06027346 2023-09-07
A Study of Bio-008 in Subjects With Advanced or Metastatic Solid Tumours
Shijiazhuang Yiling Pharmaceutical Co. Ltd
Phase 1 Recruiting